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The Guttmacher-Lancet Commission’s report on Sexual and Reproductive 
Health and Rights for All1 arrives at a time of renewed attention on sexual and 
reproductive health and rights (SRHR).  The SheDecides campaign launched in 
early 2017, is centred on the right of women and girls to bodily autonomy.  It is a 
direct response to the United States’ (US) reinstatement of the Mexico City Policy 
(also known as the Global Gag Rule), which blocks USAID funding for non-US 
organisations offering abortion services or information.  Since then we have 
witnessed the emergence of the #metoo and #timesup movements, bringing sexual 
abuse and assault squarely into the public eye.   
 
The changes are set against a backdrop of persistent and significant challenges in 
SRHR.  The Commission’s report draws attention to the scale of global SRHR need.  
More than 200 million women in developing regions want to prevent pregnancy but 
are not using effective contraception; 25 million unsafe abortions are performed each 
year worldwide; nearly 350 million men and women contract a curable sexually 
transmitted infection (STI) each year with 2 million people newly acquiring human 
immunodeficiency virus (HIV); and one-in-three women experience violence in their 
lifetime (1).  These are preventable public health problems. If all women requiring 
contraception had access to effective methods, an estimated 375 million unplanned 
pregnancies would be prevented annually (2).  With regard to HIV, advances in 
antiretroviral therapy (ART) mean that HIV is now a long-term condition with near-
normal life-expectancy for those starting treatment early (3).  Furthermore, those on 
suppressive ART cannot transmit HIV sexually (4).   
 
  Cost should not be a barrier to advancing SRHR.  SRHR investments are 
among the most cost-effective public health interventions available. For example, 
investing in modern contraception and safe childbirth is projected to generate a four-
fold return through the prevention of maternal and neonatal mortality, stillbirths and 
disability (5).There are also broader social and economic gains to be achieved 
through investing in SRHR, as outlined in the report.  Pregnancy spacing reduces 
maternal and neonatal mortality, improves infant survival through better health and 
education, increases women’s economic productivity and raises gross domestic 
product per capita. The World Health Organisation estimates a social and economic 
benefit:cost ratio of almost 9:1 of providing sexual and reproductive health (SRH) 
services, projecting this to rise to 39:1 by 2050 (6).   Finally, we must not overlook 
the importance of SRHR on an individual level.  Safe and fulfilling sex is central to 
many people’s lives and is a fundamental human right. Everyone deserves to have 
sex free from the fear of disease, violence, or unplanned pregnancy as outlined in 
the Declaration of Sexual Rights. 
 
The report outlines a bold and holistic vision for SRHR in the 21st Century.  
Improvements will not come with the implementation of effective interventions alone. 
It will have to go hand-in-hand with the advancing of rights through policy, legal 
reform, and wider social change. The Commission recommends a minimum package 
of SHRH interventions comprising: comprehensive sexuality education, 
contraception, services to safeguard maternal and newborn health, safe abortion, 
prevention and treatment of HIV and other STIs, prevention, detection and 
management of gender-based violence, infertility services, prevention, detection and 
management of reproductive cancers, and services for sexual health and wellbeing.  
Moreover, whilst emphasising that SHRH needs are universal, it rightly identifies 
groups who may have particular needs such as adolescents, sex workers, refugees, 
and those from the diverse lesbian, gay, bisexual, transgender, queer, and intersex 
(LGBTQI) communities.    
 
Yet sex is a highly-politicised topic, and progress cannot be made without 
strong leadership. Unfortunately, SRHR are under threat globally due to weak 
political will and ideologies that are increasingly at odds with the rights of women and 
minority groups.  The reinstatement of the Global Gag Rule by the US has been the 
most restrictive in recent times.  It not only restricts access to abortion care, but also 
makes it impossible for non-governmental organisations (NGOs) to deliver other 
SRH and healthcare interventions in lower income countries. The Commission rightly 
points out that as SRH becomes increasingly marginalised as a form of healthcare, 
these countries are increasingly dependent on external donations. The Global Gag 
Rule is effectively an attack on equitable SRHR.  
 
Although much of the Commission’s report is aimed at low- and middle-
income countries, the need for greater political commitment equally applies to SRH 
provision in high-income countries. Here in England, the 2012 Health and Social 
Care Act has resulted in the funding of components of sexual health services, such 
as contraception and termination of pregnancy, being spread across three separate 
public bodies (Figure 1). This fragmentation of services has been devastating for 
service provision. Furthermore, English public health budgets have been slashed, 
with sexual health shouldering a disproportionate burden of these cuts.  Sexual 
health budgets are estimated to have been reduced by £30 million since 2016 (7). A 
storm is brewing.  In 2015, the Family Planning Association warned that the current 
level of cuts could result in an extra 72,299 STI diagnoses by 2020, at a cost of £363 
million and an additional £8.3 billion spending as a result of unintended pregnancies 
(8).  We see the impact in Lambeth in London which has the highest number of STIs 
diagnosed in England.  The local sexual health service has had an 85% cut in 
funding, resulting in three clinic closures (7).  A similar picture is emerging elsewhere 
in the country.  All this comes at a time when the first case of multi-drug resistant 
gonorrhoea has been reported in the UK, a significant threat which requires more, 
not less, investment in frontline sexual health services (9). 
 
 
The Guttmacher-Lancet Commission sets out a clear and compelling 
argument for investment in SRHR.  It also highlights the inextricable link between 
SRHR and social justice, demanding a cross-specialty and cross-sectoral response.  
This report is a call to arms for healthcare providers, public health practitioners, 
governments, non-governmental organisations and civil society to recognise the 
importance of SRHR and fight for their implementation. Only by working together can 
we achieve the bold and ambitious vision of universal SRHR presented in this report. 
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